This study is not yet accepting patients
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX
Summary
- Eligibility
- for people ages 2 years and up (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Scholar Rock, Inc.
- ID
- NCT05626855
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 260 study participants
- Last Updated